Restylane vs. Juvéderm: Why the Product and Treatment Area Matter

Restylane or Juvéderm? Both names appear often in conversations about facial fillers, but choosing between them takes more than comparing brands. Each includes several hyaluronic acid fillers, with different formulations and approved uses. A product chosen for lip fullness may serve a different purpose from one used for cheek volume.

The useful question is which specific product fits your anatomy, treatment area and goals. Neither brand is the best choice for everyone. Understanding a few differences can help you have a more informed consultation.

Both brands contain different kinds of gel

Hyaluronic acid, often shortened to HA, is a substance naturally found in the body. In these fillers, it is processed into a gel and crosslinked, meaning its chains are joined together to help it last at the injection site. [2] [3]

Products differ in how they respond to pressure, hold their shape and move with surrounding tissue. Those properties can help guide product selection, but they do not predict a person's result on their own. It is too simple to describe all Restylane products as firm or all Juvéderm products as soft. [9]

A consultation should connect the product recommendation to a specific change you want to make. Ask what the gel is intended to do in that location and why it suits your tissue.

Compare products within the treatment area

For lips, Restylane Kysse and Juvéderm Volbella XC are examples with FDA-approved lip augmentation uses in adults 22 and older. Kysse also has an indication for lines in the skin above the upper lip, while Volbella XC includes lines around the mouth. Lip fullness and lines in the surrounding skin are related but distinct concerns. [2] [3]

For cheeks, Restylane Contour and Juvéderm Voluma XC have approved uses that include adding cheek volume. Voluma XC's cheek indication specifically addresses age-related volume loss in the midface. These examples do not cover every approved use. [4] [5]

For moderate to severe facial folds, including the lines running from the sides of the nose toward the mouth, options include Restylane Refyne and Juvéderm Vollure XC. [6] [7] The approved uses described here are for adults 22 and older. An assessment should consider the surrounding face.

FDA approval applies to the exact product and use. Ask whether the proposed treatment is within its approved labeling or off-label, meaning outside that labeling. These examples also do not confirm which individual products a practice currently stocks.

What a direct comparison can tell you

A randomized study compared Restylane Kysse with Juvéderm Volbella XC for lip augmentation. Kysse met the study's noninferiority goal for lip fullness eight weeks after the last injection. In plain language, its improvement was not meaningfully worse than Volbella XC within the study's predefined limit. [8]

The study followed patients for 48 weeks and allowed an optional touch-up at week four. It was industry funded. The findings support these particular products for the studied patients and purpose; they do not establish that one entire brand looks more natural, is safer or lasts longer in every treatment area.

Read duration claims in context

Duration estimates belong to a particular product, location and treatment plan. For example, Restylane Contour's cheek patient labeling describes effects lasting up to 12 months. Juvéderm Voluma XC's cheek labeling describes effects lasting up to two years in a majority of study participants. [4] [5]

These statements come from separate studies, with different designs and treatment plans. They are not a head-to-head test proving that one brand lasts twice as long. Some studies include touch-ups to reach the desired correction.

Your response and maintenance needs can differ. Ask what the clinician expects for your planned treatment, when to reassess it and whether the estimate includes additional injections. Compare the likely total cost over time, including follow-up, rather than the price of one syringe.

Plan for the result and the recovery

A natural appearance depends on the overall treatment plan, including the amount used and where it is placed. Discuss the features you want to preserve, as well as the change you hope to see. More volume is not automatically a better result.

Bruising, swelling, redness and tenderness are common after filler. Early swelling can make it difficult to judge the final contour. Recovery varies, so leave room before a major event and follow the instructions for your specific treatment. [1]

Before choosing either brand, discuss prior fillers, cold sores, allergies, medical conditions, medications and supplements. Some severe allergies rule out particular products. Treatment should be delayed when the injection area is actively inflamed or infected. Safety during pregnancy and breastfeeding has not been established. Do not stop prescribed medication without guidance from your prescriber. [3] [4]

Understand serious risks and the limits of dissolving

Both brands carry medical risks. Infection, lumps and delayed inflammation can occur. Rarely, filler enters a blood vessel and blocks circulation, potentially causing skin tissue death, vision loss including blindness, or stroke. [1]

Seek immediate medical attention for unusual pain, white, gray or blue skin near the injection site, vision changes or stroke symptoms such as sudden difficulty speaking or one-sided weakness. Do not wait for a routine review. [1]

Clinicians sometimes use hyaluronidase, an enzyme, to break down HA filler. This is an off-label use in the United States. Dissolving has its own risks, including allergic reactions. A laboratory study found that different gels broke down differently; those results cannot predict exactly how treatment will work in a person. [10] [11]

Do not assume that an unwanted result can be fully or instantly reversed. Dissolving cannot be relied on to undo every complication, including visual injury. [1] Ask how the clinician recognizes and manages complications before treatment.

Choose a plan you can explain

Before deciding, ask for the exact product name, the reason it was selected for your treatment area, expected recovery and the follow-up plan. You should also understand alternatives, including postponing treatment or choosing no procedure.

For a broader discussion of lip goals and recovery, see our lip-filler guide. To discuss Restylane or Juvéderm in Palm Beach Gardens, contact Luxe Arte Aesthetics and ask which specific options are available and appropriate for you.

This article provides general education and does not replace an individual medical assessment. Treatment suitability and results vary.

Sources and further reading

1. FDA. Dermal Fillers (Soft Tissue Fillers).
2. FDA. Restylane Kysse. Summary of Safety and Effectiveness Data, P140029/S021.
3. AbbVie. Juvéderm Volbella XC. Directions for Use.
4. FDA. About Restylane Contour. Patient labeling for cheek and midface treatment, P140029/S032.
5. AbbVie. Juvéderm Voluma XC. Patient Information Labeling for Cheek Augmentation.
6. FDA. Restylane Refyne and Restylane Defyne. Premarket Approval record, P140029.
7. AbbVie. Juvéderm Vollure XC. Directions for Use.
8. Weiss R, Beer K, Cox SE, et al. A Randomized, Controlled, Evaluator-Blinded, Multi-Center Study of Hyaluronic Acid Filler Effectiveness and Safety in Lip Fullness Augmentation. Dermatologic Surgery. 2021;47(4):527–532. doi:10.1097/DSS.0000000000002856.
9. Sundaram H, Voigts B, Beer K, Meland M. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid. Dermatologic Surgery. 2010;36(Suppl 3):1859–1865. doi:10.1111/j.1524-4725.2010.01743.x.
10. Faivre J, Wu K, Gallet M, Sparrow J, Bourdon F, Gallagher CJ. Comparison of Hyaluronidase-Mediated Degradation Kinetics of Commercially Available Hyaluronic Acid Fillers In Vitro. Aesthetic Surgery Journal. 2024;44(6):NP402–NP410. doi:10.1093/asj/sjae032.
11. DailyMed. Hylenex recombinant (hyaluronidase human injection). U.S. prescribing information, revised November 2024.